Company Performance Metrics
- Jamie Heath: CFO
Apollo Therapeutics is a collaborative venture between three UK universities (Imperial College London, University College London, and the University of Cambridge) and three global pharmaceutical companies (AstraZeneca, GlaxoSmithKline, and Johnson & Johnson Innovation). It provides committed translational funding and drug discovery expertise
for novel therapeutics, sourced from the best British academic research, accelerating them towards the clinic.
Apollo’s unique model provides quick, independent access to the resources to grow innovations and champion the best British academic research to industry. Apollo’s experienced team of industry scientists has a proven track record of therapeutic delivery and works in partnership with academics and industry partners, crafting each bespoke project to optimize the chances of long-term success. Apollo Therapeutics aims to create future therapies by partnering with the UK’s globally leading academic science base and UK-based Pharma industry to have a real impact on patient treatments and outcomes.
